Unlocking the code for the diagnosis and treatment of Alzheimer's disease (AD) requires a deep dive into the complex interplay of genetic, molecular, and clinical factors that drive disease progression. This presentation will explore the latest advancements in understanding the pathophysiology of AD, including breakthroughs in biomarker discovery, neuroimaging, and the role of amyloid and tau pathology. We will also discuss innovative diagnostic strategies, focusing on early detection and personalized medicine approaches, which are transforming how we approach this devastating condition.

On the treatment front, we will highlight recent successes in disease-modifying therapies, including monoclonal antibodies targeting amyloid and novel approaches addressing neuroinflammation and synaptic health. Special attention will be given to integrating emerging therapies with patient-centric care models to optimize outcomes. By "unlocking the code," this presentation aims to equip clinicians and researchers with actionable insights into the evolving landscape of AD diagnosis and treatment, paving the way for a future where Alzheimer's is not only treatable but also preventable.

Dr. Lin Zhang is a distinguished neurologist and the Chief of the Movement Disorders Division at UC Davis, where he leads groundbreaking research and clinical initiatives in neurology. He also serves as the Director of the Parkinson Foundation Center of Excellence for Movement Disorders and Neurorestoration, and as the Co-Director of the WDA Center of Excellence in Research and Patient Care.

With a profound commitment to advancing the understanding and treatment of movement disorders, Dr. Zhang has authored over 50 peer-reviewed publications and recently released a widely acclaimed book on Parkinson's Disease Dementia, contributing valuable insights to both the medical community and the public. His expertise and dedication to patient care have garnered him recognition, including lifetime fellowships in both the American Neurological Association (ANA) and the American Academy of Neurology (AAN).

Dr. Zhang’s work not only enhances clinical practices but also aims to improve the quality of life for individuals affected by neurodegenerative diseases. His leadership at UC Davis has positioned the institution as a leading center for research and treatment in movement disorders, fostering innovation and collaboration across disciplines.